Enhancement of Immune Checkpoint Inhibitor-Mediated Anti-Cancer Immunity by Intranasal Treatment of Ecklonia cava Fucoidan against Metastatic Lung Cancer.
Enhancement of Immune Checkpoint Inhibitor-Mediated Anti-Cancer Immunity by Intranasal Treatment of Ecklonia cava Fucoidan against Metastatic Lung Cancer.
复制标题
静脉昆布褐藻糖胶鼻内治疗增强免疫检查点抑制剂介导的抗癌免疫力对抗转移性肺癌
DOI:
10.3390/ijms22179125
复制
发表时间:
2021-08-24
影响因子:
5.6
通讯作者:
Jin JO
中科院分区:
文献类型:
--
作者:
Zhang W;Hwang J;Yadav D;An EK;Kwak M;Lee PC;Jin JO
Although fucoidan, a well-studied seaweed-extracted polysaccharide, has shown immune stimulatory effects that elicit anticancer immunity, mucosal adjuvant effects via intranasal administration have not been studied. In this study, the effect of Ecklonia cava-extracted fucoidan (ECF) on the induction of anti-cancer immunity in the lung was examined by intranasal administration. In C57BL/6 and BALB/c mice, intranasal administration of ECF promoted the activation of dendritic cells (DCs), natural killer (NK) cells, and T cells in the mediastinal lymph node (mLN). The ECF-induced NK and T cell activation was mediated by DCs. In addition, intranasal injection with ECF enhanced the anti-PD-L1 antibody-mediated anti-cancer activities against B16 melanoma and CT-26 carcinoma tumor growth in the lungs, which were required cytotoxic T lymphocytes and NK cells. Thus, these data demonstrated that ECF functioned as a mucosal adjuvant that enhanced the immunotherapeutic effect of immune checkpoint inhibitors against metastatic lung cancer.
登录
查看更多内容
影响因子:
10.9
作者:
Gong J;Chehrazi-Raffle A;Reddi S;Salgia R
通讯作者:
Salgia R
影响因子:
7.3
作者:
Cohn L;Delamarre L
通讯作者:
Delamarre L
影响因子:
8.8
作者:
通讯作者:
--
影响因子:
2.5
作者:
Bong CY;Smithers BM;Chua TC
通讯作者:
Chua TC
影响因子:
10.9
作者:
Hwang J;Zhang W;Park HB;Yadav D;Jeon YH;Jin JO
通讯作者:
Jin JO